In a human melanoma xenograft model, additional transduction of NY-ESO-1-specific TCR-T cells expressing active IL18 resulted in a significant increase in the number of viable T cells in peripheral blood and inhibition of tumor progression [355]. This evidence concerns the gene IL18 and melanoma.